NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 10, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today reported that it has received approval to Start Phase II Clinical Trial of ...
For the first time, thanks to CRISPR scissors, the genome of reptiles has been edited. American researchers have managed to ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Health experts are alarmed as Republicans degrade the country’s pivotal HIV programs — and break promises made during Trump’s ...
Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own. Critics call the move self-defeating.
“Turkey’s involvement in the stabilization of Gaza is seen as a crucial step towards achieving peace and security in the ...
Addressing the paradox of cleaner air uncovering hidden warming demands integrating air-quality and climate policy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback